CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
35.710
2.24%
Market Trading Hours* (UTC) Opens on Wednesday at 08:00

Mon - Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.090
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.018635 %
Charges from full value of position ($-3.54)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.018635%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.003587 %
Charges from full value of position ($-0.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.003587%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 36.53
Open 36.06
1-Year Change -11.43%
Day's Range 35.685 - 36.53
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 11, 2025 35.710 -0.115 -0.32% 35.825 36.555 35.665
Mar 10, 2025 36.530 0.065 0.18% 36.465 36.740 36.210
Mar 7, 2025 36.480 -0.305 -0.83% 36.785 36.950 36.310
Mar 6, 2025 36.960 1.130 3.15% 35.830 36.990 35.655
Mar 5, 2025 35.700 0.145 0.41% 35.555 36.090 35.075
Mar 4, 2025 35.785 -0.730 -2.00% 36.515 36.590 35.720
Mar 3, 2025 36.810 0.755 2.09% 36.055 37.180 36.055
Feb 28, 2025 36.900 -0.050 -0.14% 36.950 37.100 36.755
Feb 27, 2025 37.095 0.010 0.03% 37.085 37.370 36.835
Feb 26, 2025 37.625 -0.055 -0.15% 37.680 37.835 37.420
Feb 25, 2025 37.700 -0.480 -1.26% 38.180 38.315 37.665
Feb 24, 2025 38.135 0.200 0.53% 37.935 38.360 37.525
Feb 21, 2025 37.380 0.490 1.33% 36.890 37.530 36.575
Feb 20, 2025 37.525 0.000 0.00% 37.525 37.690 37.370
Feb 19, 2025 37.565 -0.590 -1.55% 38.155 38.235 37.315
Feb 18, 2025 38.215 0.050 0.13% 38.165 38.420 38.055
Feb 17, 2025 38.265 0.480 1.27% 37.785 38.305 37.740
Feb 14, 2025 37.930 -0.060 -0.16% 37.990 38.435 37.805
Feb 13, 2025 38.665 0.685 1.80% 37.980 38.860 37.980
Feb 12, 2025 38.315 0.250 0.66% 38.065 38.835 38.035

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Qiagen Company profile

About Qiagen NV

Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Qiagen NV revenues increased 20% to $2.25B. Net income increased 43% to $512.6M. Revenues reflect Consumables and Related Revenues segment increase of 23% to $1.99B, Instrumentation segment increase of 4% to $265.3M, United States segment increase of 25% to $909.7M, Europe & Middle East & Afric segment increase of 19% to $814.4M. Net income benefited from Restructuring decrease of 81% to $27.8M (expense).

Equity composition

1/2017, Shares Consolidation (Factor: 0.96296).

Industry: Biotechnology & Medical Research (NEC)

Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL

People also watch

Gold

2,918.60 Price
+1.000% 1D Chg, %
Long position overnight fee -0.0168%
Short position overnight fee 0.0086%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

82,352.55 Price
+3.510% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

19,422.50 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0235%
Short position overnight fee 0.0012%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

1,880.89 Price
+0.590% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Still looking for a broker you can trust?

Join the 690,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading